Arpeggio Biosciences is a startup based in the United States, 2 tracked investors.
Based in the United States, Arpeggio Biosciences is a startup. Brouky records 2 investors associated with the company.
Arpeggio Biosciences develops a drug-discovery technology that reads cell transcriptional changes to screen the activity of tens of thousands of compounds across diseased and healthy cells. The platform has established strategic partnerships with major pharmaceutical companies including Pfizer, Janssen, Genentech and Novartis.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.